stockrow
Friday 6 November 2026
Export PCVX’s income statement to Excel — free account
Vaxcyte, Inc.
PCVX Healthcare Biotechnology
- EPS
- −27.9%
- Free cash flow
- −92.6%
Quarter to September 2026, against a year earlier
63.82
1.90
+3.07%
Follow PCVX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
7.91 | 7.49 | 5.72 | 4.56 |
Net Debt/EBITDA |
5.84 | 5.06 | 4.99 | 4.02 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 3.24% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.04 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.91 | 0.88 | 0.82 | 0.75 | |
Capex/Depreciation |
(0.38) | (0.77) | (0.91) | (0.30) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.67) | (2.03) | (1.64) | (1.53) | |
Cash per Share |
11.47 | 12.45 | 10.29 | 8.68 | |
Shareholders Equity per Share |
19.73 | 21.48 | 19.09 | 16.72 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.73 | 21.48 | 19.09 | 16.72 | |
Free Cash Flow |
(227.49) | (282.73) | (236.79) | (227.42) | |
Working Capital |
1,421.61 | 1,571.41 | 1,281.39 | 1,053.86 | |
Capital Expenditures |
(2.65) | (2.11) | (4.32) | (3.33) | |
Net Current Asset Value |
1,310.15 | 1,461.19 | 1,172.46 | 849.64 | |
| Other line items | |||||
Quick Ratio |
7.59 | 7.18 | 5.48 | 4.37 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.65) | (2.01) | (1.61) | (1.50) | |
Capex per Share |
(0.02) | (0.02) | (0.03) | (0.02) | |
Average Payables |
59.68 | 41.79 | 66.17 | 58.29 | |
Average Assets |
3,257.02 | 3,363.21 | 3,221.76 | 3,080.37 | |
Average Common Equity |
2,995.66 | 3,098.02 | 2,914.64 | 2,691.05 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026